8AH-32035-67226
2 vaccinations
4 coded responses
18 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 150 / PA
- Registered
- 2022-06-27
- Relationship
- Child or adolescent in my care
- Guardian
- QRS-26252-83220
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-27
Registered in v-safe
-
2022-06-28
Dose 1 — Pfizer-BioNTech
- 2022-06-30
-
2022-07-02
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
-
2022-07-03
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Medical counselling — Feeling: Poor · Fever · Sleepiness, Irritability/crying, Loss of appetite · Get care from a doctor or other healthcare professional · HospitalizationFree text: Called on call doctor for adviceMedDRA releases: 2024-11 · check-in free text available
-
2022-07-03
Report sent to call center — days 1–6 daily, dose 1, under 3Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-07-04
- 2022-07-05
-
2022-07-05
Call successfulDoes not wish to fill out VAERS report
-
2022-07-12
Survey response — day 14, dose 1, under 3MedDRA: Productive cough, Rhinorrhoea — Feeling: GoodFree text: Runny nose and wet coughMedDRA releases: 2024-11 · check-in free text available
- 2022-07-19
-
2022-07-22
Dose 2 — Pfizer-BioNTech
- 2022-07-26
- 2022-07-27
- 2022-07-28
-
2022-07-29
Survey response — day 7, dose 2, under 3MedDRA: Adverse reaction — Feeling: Fair · Irritability/cryingFree text: Symptoms could possibly be teethingMedDRA releases: 2024-11 · check-in free text available
- 2022-08-05
- 2022-08-14
- 2022-08-19
- 2022-08-26
- 2022-09-02
- 2022-10-21
-
2023-01-20
Survey response — 6 months, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-28 | Pfizer-BioNTech | No |
| 2 | 2022-07-22 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Healthcare visit (other): Called on call doctor for advice
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Runny nose and wet cough
Release 12 (Under 3) — day 7, dose 2, under 3
Systemic reaction (other): Symptoms could possibly be teething
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Adverse reaction | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release